semaglutide 2.4 mg obesity Two-year effects of in adults with overweight or obesity: the STEP 5 trial Semaglutide 2.4 mg weekly vs

Besides allowing you to feel fuller longer by slowing down the rate at which your stomach empties, semaglutide helps control your appetite in another way

At 50% uptake, and assuming a 15.5% discontinuation rate as observed in the SOUL trial, an estimated 59,332 MACE, 14,215 cardiovascular deaths, 41,744 nonfatal myocardial infarctions, and 12,260 nonfatal strokes could be prevented

Under medical supervision, theyre prescribed as part of a personalized weight loss program that may include B12 shots, lifestyle guidance, and nutrition support

The study also revealed a statistically significant drop in IOP after starting GLP-1 receptor agonist treatment, especially in those with a history of glaucoma or pre-existing excessive IOP. The researchers also found that GLP-1 agonist use in the management of type 2 diabetes may have possible cardiovascular advantages